12.11.2012 Views

Nicotine replacement therapy … - Carlos A ... - Entretiens du Carla

Nicotine replacement therapy … - Carlos A ... - Entretiens du Carla

Nicotine replacement therapy … - Carlos A ... - Entretiens du Carla

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Effective<br />

treatments for<br />

Smoking<br />

Cessation in<br />

pregnancy<br />

A Cochrane review summarised evidence<br />

for the effectiveness of smoking cessation<br />

programmes delivered outside of routine<br />

ante-natal care finding that these re<strong>du</strong>ce<br />

rates of smoking late pregnancy by around<br />

6% (relative risk 0.94, 95% CI 0.93 - 0.95) (9).<br />

Ante natal smoking cessation programmes<br />

also re<strong>du</strong>ced the incidences of low birth<br />

weight and pre-term birth by approximately<br />

20% from baseline levels (9).<br />

Trials included in the review tested varied<br />

behavioural interventions which were<br />

underpinned by different psychological<br />

theories and it is not possible to say which of<br />

programmes’ indivi<strong>du</strong>al behavioural<br />

components were effective. Most trials<br />

employed cognitive/behavioural strategies<br />

to encourage cessation, but two which used<br />

social support and reward approaches<br />

caused bigger re<strong>du</strong>ctions in smoking rates<br />

(approximately 23%). In contrast,<br />

programmes based around the “stages of<br />

change” theory were not effective.<br />

The Cochrane review also pooled data<br />

from three trials which, at that time, had<br />

investigated the impact of nicotine<br />

<strong>replacement</strong> <strong>therapy</strong> (NRT) for smoking<br />

cessation in pregnancy and found no<br />

evidence that this was effective (pooled RR<br />

for cessation in later pregnancy 0.94: 95% CI<br />

0.89, 1.00). Given that smoking cessation<br />

programmes delivered alongside their<br />

routine ante-natal care are effective, these<br />

should be offered to all pregnant women<br />

and any. Pharmacological smoking cessation<br />

aids should only be provided in addition to<br />

these.<br />

37<br />

Using medicinal<br />

nicotine in<br />

pregnancy<br />

Although behavioural treatments for<br />

smoking cessation in pregnancy work,<br />

women who use these need to be motivated<br />

enough to set aside significant amounts to<br />

attend treatment and it is not likely that<br />

those smokers who are very negative about<br />

the benefits of stopping smoking will do so.<br />

Consequently, it is important to find other<br />

smoking cessation treatments which are safe<br />

and effective but which are also more likely<br />

to be used by recalcitrant smokers. One such<br />

potential treatment which has been<br />

recommended for use in pregnancy is<br />

nicotine <strong>replacement</strong> <strong>therapy</strong> (NRT) (10).<br />

Over 100 trials of NRT in non-pregnant<br />

subjects have consistently demonstrated<br />

that, irrespective of NRT formulation used,<br />

this is more effective than placebo for<br />

smoking cessation and increases the chances<br />

of a smoker achieving abstinence in any one<br />

quit attempt by around 80% (RR 1.77 [95%<br />

CI 1.66, 1.88]) (11). Additionally, the impact<br />

of NRT appears to be independent of the<br />

amount or intensity of support provided, the<br />

treatment <strong>du</strong>ration or the setting in which<br />

this is offered. If effective, therefore, NRT<br />

could be an acceptable alternative treatment<br />

for pregnant women who cannot or will not<br />

attend for support with smoking cessation.<br />

Although there is very little evidence for<br />

either the effectiveness or safety of NRT<br />

when used for smoking cessation in<br />

pregnancy, many smoking cessation experts<br />

believe that use of NRT in pregnancy is<br />

preferable to smoking (12). They argue that,<br />

although toxic, nicotine is a substance which<br />

pregnant women would receive anyway if<br />

they continued to smoke and that when it is<br />

delivered by NRTs nicotine is not<br />

accompanied by the numerous over known<br />

tobacco smoke toxins. Additionally, it has<br />

also been argued that because, outside of<br />

Recommendations <strong>du</strong>ring pregnancy - Tim Coleman<br />

(7) Bolling K. Infant<br />

Feeding Survey 2005:<br />

Early Results. 2006.<br />

http://www.ic.nhs.uk/pu<br />

bs/breastfeed2005, The<br />

National Health Service<br />

Information Centre for<br />

Health and Social Care.<br />

(8) Owen L, Penn G.<br />

Smoking and pregnancy:<br />

A survey of knowledge<br />

attitudes and behaviour,<br />

1992-1999. 1999.<br />

London, Health<br />

Development Agency.<br />

Ref Type: Report<br />

(9) Lumley J, Oliver SS,<br />

Chamberlain C, Oakley<br />

L. Interventions for<br />

promoting smoking<br />

cessation <strong>du</strong>ring<br />

pregnancy.[update of<br />

Cochrane Database Syst<br />

Rev. 2000; (2): CD001055;<br />

PMID:<br />

10796228].Cochrane<br />

Database of Systematic<br />

Reviews 2004; (4):<br />

CD001055.<br />

(10) Benowitz NL,<br />

Dempsey DA,<br />

Goldenberg RL, Hughes<br />

JR, Dolan-Mullen P,<br />

Ogburn PL et al. The use<br />

of pharmacotherapies<br />

for smoking cessation<br />

<strong>du</strong>ring pregnancy. Tob<br />

Control 2000; 9 Suppl 3:<br />

III91-III94.<br />

(11) Silagy C, Lancaster<br />

T, Stead L, Mant D,<br />

Fowler G. <strong>Nicotine</strong><br />

<strong>replacement</strong> <strong>therapy</strong> for<br />

smoking cessation.[see<br />

comment][update of<br />

Cochrane Database Syst<br />

Rev. 2002;(4):CD000146;<br />

PMID: 12519537].<br />

Cochrane Database of<br />

Systematic Reviews<br />

2004; (3): CD000146.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!